Meenakshi A Chellaiah Selected Research

Neoplasm Metastasis (Metastasis)

2/2019	Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2.
1/2019	Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells.
1/2017	CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells.
9/2012	Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.
8/2009	Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meenakshi A Chellaiah Research Topics

Disease

13	Bone Resorption 04/2021 - 06/2003
8	Prostatic Neoplasms (Prostate Cancer) 07/2020 - 03/2007
7	Neoplasms (Cancer) 02/2019 - 03/2007
5	Neoplasm Metastasis (Metastasis) 02/2019 - 08/2009
3	Wiskott-Aldrich Syndrome 03/2007 - 09/2005
2	Osteoporosis 04/2021 - 08/2009
1	Osteoarthritis 01/2021
1	Pancreatitis 01/2021
1	Periodontal Diseases (Periodontal Disease) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Spontaneous Fractures (Pathological Fracture) 09/2012
1	Carcinogenesis 01/2010

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2005
5	plastinIBA 04/2021 - 09/2010
5	OsteopontinIBA 01/2019 - 03/2007
4	Peptides (Polypeptides)IBA 04/2021 - 05/2004
3	GelsolinIBA 04/2006 - 05/2004
2	PeptidomimeticsIBA 04/2021 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 07/2020 - 01/2019
2	AndrogensIBA 02/2019 - 09/2012
2	LigandsIBA 01/2017 - 09/2012
2	IntegrinsIBA 09/2012 - 03/2007
1	dimethyl sulfone (methylsulfonylmethane)IBA 01/2021
1	Tartrate-Resistant Acid PhosphataseIBA 01/2021
1	ProcollagenIBA 01/2021
1	OsteocalcinIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	PhycocyaninIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 02/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	adhesion receptorIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2013
1	CurcuminIBA 05/2013
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2013
1	NF-kappa B (NF-kB)IBA 09/2012
1	Mitogen-Activated Protein KinasesIBA 09/2010
1	Macrophage Colony-Stimulating FactorIBA 09/2010
1	CortactinIBA 09/2010
1	beta CateninIBA 01/2010
1	Diphosphonates (Bisphosphonates)IBA 08/2009
1	Wiskott-Aldrich Syndrome ProteinIBA 02/2008
1	Actins (F Actin)IBA 02/2008
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 02/2008
1	Amino Acids FDA Link 02/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2007
1	Phosphotransferases (Kinase)IBA 03/2007
1	Non-Receptor Type 12 Protein Tyrosine PhosphataseIBA 03/2007
1	Small Interfering RNA (siRNA)IBA 03/2007
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2004
1	Phosphatidylinositol PhosphatesIBA 05/2004
1	rho-Associated KinasesIBA 08/2003
1	Neutralizing AntibodiesIBA 08/2003
1	Adenosine Triphosphate (ATP)IBA 06/2003
1	Phosphates (Orthophosphate)IBA 06/2003

Therapy/Procedure

2	Therapeutics 01/2019 - 09/2012